Beyond Inc to Acquire Buy Buy Baby Brand Rights Reuniting with Bed Bath Beyond Asia Pacific Real Estate Investment Surges 19 in Q1 India Emerges as Key Logistics and Data Centre Hub Savills Report 2Pacs Dear Mama Reaches Billboard Top 10 Nearly Three Decades After Release Highlighting Catalog Value Kevin Warsh Poised for Internal Fed Clash Over Rate Cuts Amid Inflation and Yield Pressure Berkshire Hathaway Revives Airline Bet with 26 Billion Stake in Delta Air Lines Contrarian Signal Emerges as Market Timers Rush for Exits Loop Industries Q1 2026 Earnings Narrowerthanexpected loss amid steady technology development PCVX Q1 2026 Earnings Wider Than Expected Loss as PreRevenue Biotech Advances Vaccine Pipeline Red River Bancshares Q1 2026 Earnings EPS Surpasses Estimates Despite Modest Stock Decline AIFF Q3 1998 Earnings Massive EPS Miss as Revenue Remains Unreported New Pacific Metals Corp NEWP Q1 2026 Earnings EPS Miss Marks Quarter of Operational Progress Amid Narrowing Losses Exzeo Group Inc XZO Q1 2026 Earnings EPS Beats Estimates by 521 Stock Edges Higher WD40 Company WDFC Dips 105 as Shares Approach Key Support Level 60 Degrees Pharmaceuticals SXTP Slips 6 as Shares Test Key Support Corpay Inc CPAY Holds Steady Near Support as Consolidation Continues Taylor Devices Inc TAYD Edges Higher Nears Key Resistance at 5571 Highlander Silver Corp HSLV Gains 238 as Silver Sector Momentum Builds Omada Health Q1 2026 Earnings Narrower Loss Beat Estimates as Company Focuses on Operational Efficiency Radian Group Q1 2026 Earnings BEPS Beat Estimates Despite Broader Market Headwinds UZD Q1 2026 Earnings EPS Surges Past Estimates by 895 as Digital Infrastructure Demand Holds CTOS Q1 2026 Earnings EPS Surprises with Smaller Loss but Stock Dips CMPS Q1 2026 Earnings Loss Narrower Than Expected as Company Advances Clinical Pipeline CAKE Q1 2026 Earnings EPS Beats Estimates Amid Steady Operations Japan to Welcome First Crude Cargo via Strait of Hormuz Since Regional Conflict Escalated ACTU Q1 2026 Earnings EPS Misses Estimates as Biotech Firm Continues RD Investment Title Eastern Company EML Holds Steady at 2126 as Support and Resistance Levels Remain Key